(Q37892336)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Mechanisms of disease: pulmonary arterial hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

main subject

arterial hypertension

0 references

author

Ralph T Schermuly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ardeschir Ghofrani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Friedrich Grimminger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Martin R Wilkins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

21 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Cardiology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

443-455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

Updated clinical classification of pulmonary hypertension.

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Survival in schistosomiasis-associated pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Cardiopulmonary manifestations of hepatosplenic schistosomiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pulmonary vascular disease in the developing world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Development and pathology of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pulmonary artery compliance: its role in right ventricular-arterial coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pathobiology of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Disruption of methylarginine metabolism impairs vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

An integrated approach for the systematic identification and characterization of heart-enriched genes with unknown functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Role of K+ channels in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

The effects of vasoactivity and hypoxic pulmonary hypertension on extralobar pulmonary artery biomechanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Cardiac and lung VEGF mRNA expression in chronically hypoxic and monocrotaline-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Vascular endothelial growth factor of the lung: friend or foe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Fibroblast growth factor mediates hypoxia-induced endothelin-- a receptor expression in lung artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Role of epidermal growth factor inhibition in experimental pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

PDGF receptor and its antagonists: role in treatment of PAH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Gene transfer of hepatocyte growth factor with prostacyclin synthase in severe pulmonary hypertension of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Genetics and genomics of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Lung mast cells in plexogenic pulmonary arteriopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Mast cell chymase in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Autoimmunity and pulmonary hypertension: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Atheromas of the thoracic aorta: clinical and therapeutic update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: remodeling revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Notch signaling: cell fate control and signal integration in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Notch signaling in vascular morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Notch3 is required for arterial identity and maturation of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Notch signaling represses myocardin-induced smooth muscle cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Hypoxia requires notch signaling to maintain the undifferentiated cell state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Notch3 signaling promotes the development of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Adipogenesis and obesity: rounding out the big picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Endothelial progenitor cells for postnatal vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELM alpha) recruits bone marrow-derived cells to the murine pulmonary vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Increased superoxide production contributes to the impaired angiogenesis of fetal pulmonary arteries with in utero pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Inflammation, growth factors, and pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Inflammation, immunological reaction and role of infection in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

The role of infectious agents in the pathogenesis of systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Expression of human herpesvirus 8 in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

TGF-beta signaling controls embryo development in the parasitic flatworm Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pulmonary hypertension and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Interleukin-6 overexpression induces pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

A new class of membrane-bound chemokine with a CX3C motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Thrombotic arteriopathy and anticoagulation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Alterations of cellular bioenergetics in pulmonary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Metabolic modulation of glioblastoma with dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Integrins in mechanotransduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pressure overload-induced right ventricular failure is associated with re-expression of myocardial tenascin-C and elevated plasma tenascin-C levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Fhl-1, a new key protein in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Attenuated K+ channel gene transcription in primary pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Lung mast cell density and distribution in chronically hypoxic animals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Elastase and the pathobiology of unexplained pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Matrix metalloproteinases in the urine of patients with pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Activation of proMMP-2 and Src by HHV8 vGPCR in human pulmonary arterial endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Pulmonary hypertension in rats. 2. Role of interleukin-6

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Chemokine RANTES in Severe Pulmonary Arterial Hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Right ventricular ischemia in patients with primary pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Right coronary artery flow impairment in patients with pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.87

Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension

31 March 2020

1 reference

12 December 2020

Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.

1 reference

12 December 2020

Effects of peroxisome proliferator-activated receptor gamma ligands on monocrotaline-induced pulmonary hypertension in rats

1 reference

12 December 2020

Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells

1 reference

12 December 2020

Monocrotaline induces interleukin-6 mRNA expression in rat lungs

1 reference

12 December 2020

Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients

1 reference

12 December 2020

Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats

1 reference

12 December 2020

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2011.87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PMC publication ID

7097518

0 references

1 reference